Heike Mitschulat

Title: Heike Mitschulat: Innovator in Blood Plasma Treatment

Introduction

Heike Mitschulat is a notable inventor based in St. Wendel, Germany. She has made significant contributions to the field of medical technology, particularly in the treatment of blood plasma. Her innovative work focuses on reducing the concentration of fibrinogen and fibrin, which are critical factors in blood coagulation.

Latest Patents

Heike Mitschulat holds a patent for a process that manufactures an adsorbent designed to reduce the concentration of fibrinogen and/or fibrin in blood or blood plasma. The patent describes a method where a carrier material, preferably a copolymer derived from (meth)acrylates and/or (meth)acrylic acid amides, is activated through amination and then subjected to thermal treatment at temperatures exceeding 100°C. This process leads to the creation of an adsorber that effectively reduces fibrinogen and fibrin levels in blood or blood plasma.

Career Highlights

Heike Mitschulat is currently employed at Fresenius Hemocare GmbH, where she continues to advance her research and development efforts. Her work has been instrumental in improving medical treatments related to blood disorders.

Collaborations

Heike has collaborated with esteemed colleagues such as Hans-Peter Leinenbach and Wolfgang Metzger, contributing to a dynamic research environment that fosters innovation and development in medical technology.

Conclusion

Heike Mitschulat's contributions to the field of blood plasma treatment exemplify her dedication to medical innovation. Her patented process for manufacturing an adsorbent showcases her expertise and commitment to improving healthcare outcomes.